Trevi Therapeutics, Inc. (TRVI) Social Stream
Trevi Therapeutics Inc (TRVI) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering TRVI.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 38 weeks, TRVI's average price target has gone down $3.67.
Over the past 40 weeks, TRVI's average upside potential has been 515.18%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
TRVI Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 92 days, TRVI's average broker recommendation rating worsened by 0.5.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how Trevi Therapeutics Inc fares relative to all US stocks, note that its number of analysts covering the stock is greater than 14.13% of that group.
- In the context of Pharmaceutical Products stocks, Trevi Therapeutics Inc's variance in analysts' estimates is lower than 83.49% of them.
- In terms of how Trevi Therapeutics Inc fares relative to Healthcare stocks, note that its average analyst price target is greater than 53.22% of that group.
- In the context of Healthcare stocks, Trevi Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 305.15% of them.
Make investment decisions regarding TRVI using the data that counts. Try POWR Ratings for free.